VALSARTAN DEXCEL 80

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
VALSARTAN
Available from:
DEXCEL PHARMA TECHNOLOGIES LTD
ATC code:
C09CA03
Pharmaceutical form:
FILM COATED TABLETS
Composition:
VALSARTAN 80 MG
Administration route:
PER OS
Prescription type:
Required
Manufactured by:
DEXCEL LTD, ISRAEL
Therapeutic group:
VALSARTAN
Therapeutic area:
VALSARTAN
Therapeutic indications:
Valsartan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan significantly reduced hospitalisations for heart failure. There is no evidence that Valsartan provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.For treatment of hypertension.
Authorization number:
147 20 33426 00
Authorization date:
2016-12-31

Documents in other languages

Patient Information leaflet Patient Information leaflet - Arabic

25-01-2021

Patient Information leaflet Patient Information leaflet - Hebrew

08-03-2017

Similar products

Search alerts related to this product

View documents history

Share this information